Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm ...
In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...
Marcum Wealth LLC raised its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 19.7% in the fourth quarter, ...
Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare ...
Pfizer has reduced its stake in the British healthcare company Haleon PLC to 7.3% by selling £2.5 billion ($3 billion) worth of shares, according to a bookrunner for the sale. J.P. Morgan Securities ...